Lohmann & Rauscher Suprasorb CNP P3 Gebrauchsanweisung Seite 111

The Suprasorb CNP P3 therapy unit is approved in accordance with Regulation (EU) 2017/745
®
of the European Parliament and of the Council and fulfils in particular the essential safety and
performance requirements of Annex I of the same regulation.
The Suprasorb CNP P3 therapy unit has been classified as a Class IIa medical device in
®
accordance with Annex VIII, Rule 12 of Regulation (EU) 2017/745.
The Suprasorb CNP P3 therapy unit fulfils the requirements of IEC 60601-1-2
®
"Electromagnetic compatibility – Medical electrical devices". This reduces electromagnetic
interference and interactions to a minimum.
The quality management system in place at L&R has been certified in accordance with the
pertinent international standards.
Last revised 04-2025
Copyright © 2025 Lohmann & Rauscher International GmbH & Co. KG
© Reproduction of this document, including excerpts from it, is not permitted. Without written
approval from L&R, neither the contents as a whole nor parts thereof may be reproduced,
copied or passed on to third parties in any form whatsoever.
Subject to change without notice. Errors and omissions excepted.